Impact of Thoracic Radiotherapy on First-Line Treatment Outcomes in ES-SCLC Patients

被引：0
|
作者：
Xiaoli, M. [1 ]
Yan, L. [2 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[2] Lung Canc Ctr, Chengdu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Thoracic Radiotherapy; first-line immunotherapy and chemotherapy; extensive-stage small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.13D.08
引用
收藏
页码：S678 / S678
页数：1
相关论文
共 50 条
  • [1] Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients
    Mu, Xiaoli
    Zhou, Yixin
    Liu, Qing
    Wang, Jiantao
    Xu, Feng
    Luo, Feng
    Wang, Ke
    Li, Lu
    Tian, Panwen
    Li, Yalun
    Liu, Jiewei
    Zhang, Yan
    Liu, Jiyan
    Li, Yan
    CANCER MEDICINE, 2024, 13 (17):
  • [2] Benefit of Thoracic Radiotherapy Following First-Line Chemoimmunotherapy in ES-SCLC: Stratified by Clinical and Therapeutic Characteristics
    Wu, J.
    Li, J.
    Wang, S.
    Zhang, J.
    Sun, H.
    Ge, Y.
    Cheng, Q.
    Sun, Y.
    Wang, D.
    Fu, X.
    Sun, Y.
    Gao, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E80 - E81
  • [3] Recent advances and future strategies in first-line treatment of ES-SCLC
    Gomez-Randulfe, Igor
    Leporati, Rita
    Gupta, Brinda
    Liu, Stephen
    Califano, Raffaele
    EUROPEAN JOURNAL OF CANCER, 2024, 200
  • [4] Radiotherapy in ES-SCLC
    Gore, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S227 - S228
  • [5] Extended-stage SCLC (ES-SCLC) patients treated with first-line chemotherapy plus atezolizumab in Spain: Characteristics and outcomes
    Gomez-Mugarza, P.
    Laguna, S.
    Zapata, M.
    Prado, L. Fernandez
    Gimeno, J.
    Nuno, A.
    Galan, N.
    Arnaiz, I. Gil
    Artal-Cortes, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S135 - S136
  • [6] Efficacy of First-Line Tislelizumab Plus Etoposide and Carboplatin in ES-SCLC
    Qian, C.
    Li, X.
    Zhou, B.
    Yuan, X.
    Jiang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S697 - S698
  • [7] Which Patients with ES-SCLC Should Receive Thoracic Radiotherapy (TRT) Routinely?
    Slotman, Berend
    Faivre-Finn, Corinne
    Van Tinteren, Harm
    Praag, John
    Knegjens, Joost
    El Sharouni, Sherif
    Hatton, Matthew
    Keijser, Astrid
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S193 - S193
  • [8] ROLE OF RADIOTHERAPY IN ES-SCLC
    Slotman, Ben
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S186 - S187
  • [9] Second-line treatment outcomes in Extensive Stage Small Cell Lung Cancer (ES-SCLC) patients after first-line immuno-chemotherapy
    Wan, Rui
    Fan, Linjie
    Zhong, Jia
    Duan, Jianchun
    Wang, Zhijie
    Hao, Xuezhi
    Wang, Jie
    CANCER RESEARCH, 2024, 84 (06)
  • [10] LUMINANCE: A Phase IIIb Study of Durvalumab plus Platinum-Etoposide for First-Line Treatment of Extensive-Stage SCLC (ES-SCLC)
    Reinmuth, N.
    DeMarinis, F.
    Leighl, N.
    Sadow, S.
    Davey, K.
    Ozguroglu, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S547 - S547
12345